Cited by 207Alzheimer's disease research and treatmentsExtracellular vesicles in diseaseDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.

CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease

Open access

Shi, Min, Kovac, Andrej, Korff, Ane, Cook, Travis J., Ginghina, Carmen, Bullock, Kristin M., Yang, Li, Stewart, Tessandra, Zheng, Danfeng, Aro, Patrick, Atik, Anzari, Kerr, Kathleen F., Zabetian, Cyrus P., Peskind, Elaine R., Hu, Shu‐Ching, Quinn, Joseph F., Galasko, Douglas R., Montine, Thomas J., Banks, William A., Zhang, Jing·2016·Alzheimer's & Dementia

DOI 10.1016/j.jalz.2016.04.003PMC PMC5107127

Open this paper in CoChat — free account

Abstract

Introduction: Alzheimer's disease (AD) and Parkinson's disease (PD) involve tau pathology. Tau is detectable in blood, but its clearance from neuronal cells and the brain is poorly understood. Methods: Tau efflux from the brain to the blood was evaluated by administering radioactively labeled and unlabeled tau intracerebroventricularly in wild‐type and tau knock‐out mice, respectively. Central nervous system (CNS)–derived tau in L1CAM‐containing exosomes was further characterized extensively in human plasma, including by single molecule array technology with 303 subjects. Results: The efflux of Tau, including a fraction via CNS‐derived L1CAM exosomes, was observed in mice. In human plasma, tau was explicitly identified within L1CAM exosomes. In contrast to AD patients, L1CAM exosomal tau was significantly higher in PD patients than controls and correlated with cerebrospinal fluid tau. Conclusions: Tau is readily transported from the brain to the blood. The mechanisms of CNS tau efflux are likely different between AD and PD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2016.04.003

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
Rissin, D. M., Kan, C. W., Campbell, T. G., Howes, S. C., Fournier, D. R., Song, L., Piech, T., Patel, P. P., Chang, L., Rivnak, A. J., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1641 · Cited by 2,119
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis
Dragovic, R., Gardiner, C., Brooks, A. S., Tannetta, D., Ferguson, D. J. P., Hole, P., Carr, B., Redman, C. W. G., Harris, A. L., Dobson, P. J., et al. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.04.003 · Cited by 1,368
Tau pathology and neurodegeneration
Spillantini, M. G., & Goedert, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70090-5 · Cited by 1,133
Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control study
Fiandaca, M. S., Kapogiannis, D., Mapstone, M., Boxer, A., Eitan, E., Schwartz, J. B., Abner, E. L., Petersen, R. C., Federoff, H. J., Miller, B. L., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.06.008 · Cited by 959
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
Shi, M., Liu, C., Cook, T. J., Bullock, K. M., Zhao, Y., Ginghina, C., Li, Y., Aro, P., Dator, R., He, C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1314-y · Cited by 676
Self-citation
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
Hong, Z., Shi, M., Chung, K. A., Quinn, J. F., Peskind, E. R., Galasko, D., Jankovic, J., Zabetian, C. P., Leverenz, J. B., Baird, G., et al. (2010) · Brain · doi:10.1093/brain/awq008 · Cited by 615
Self-citation
Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease
Edwards, T. L., Scott, W. K., Almonte, C., Burt, A., Powell, E. H., Beecham, G. W., Wang, L., Zuchner, S. L., Konidari, I., Wang, G., et al. (2010) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2009.00560.x · Cited by 471
Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
Shi, M. Y., Bradner, J. M., Hancock, A. M., Chung, K. A., Quinn, J. F., Peskind, E. R., Galasko, D., Jankovic, J. J., Zabetian, C. P., Kim, H. M., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22311 · Cited by 422
Self-citation

Flagged first, then by citations

Show all 29 references

1 of the 29 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Davson H, 1996, The return of the cerebrospinal fluid to the blood: the drainage mechanism. Physiology of the CSF and blood‐brain barriers, 489

Sorted by citations

Items 101–200 of 207

Extracellular Vesicles as Biomarkers for Parkinson’s Disease: How Far from Clinical Translation?
Gualerzi, A., Picciolini, S., Bedoni, M., Guerini, F. R., Clerici, M., & Agliardi, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021136 · Cited by 32
Molecular pathways and diagnosis in spatially resolved Alzheimer’s hippocampal atlas
Wang, P., Han, L., Wang, L., Tao, Q., Guo, Z., Luo, T., He, Y., Xu, Z. P., Yu, J., Liu, Y., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.03.002 · Cited by 36
Self-citation
Alzheimer’s disease and related dementias diagnosis: a biomarkers meta-analysis of general and CNS extracellular vesicles
Taha, H. B. (2025) · npj Dementia · doi:10.1038/s44400-024-00002-y · Cited by 31
Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders
Spencer, B. J., Brüschweiler, S., Sealey‐Cardona, M., Rockenstein, E. M., Adame, A., Florio, J. B., Mante, M., Trinh, I., Rissman, R. A., Konrat, R., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1869-0 · Cited by 30
Vitamin D-binding protein in plasma microglia-derived extracellular vesicles as a potential biomarker for major depressive disorder
Zhang, G., Li, L., Kong, Y., Xu, D., Bao, Y., Zhang, Z., Liao, Z., Jiao, J., Fan, D., Long, X., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.049 · Cited by 30
Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium
Guttuso, T. J., Andrzejewski, K. L., Lichter, D. G., & Andersen, J. K. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.05.016 · Cited by 29
The Potential for Extracellular Vesicles in Nanomedicine: A Review of Recent Advancements and Challenges Ahead
Ebrahimi, F., Kumari, A., Ghadami, S., Abdullah, S. A., & Dellinger, K. (2024) · Advanced Biology · doi:10.1002/adbi.202400623 · Cited by 31
Detection and Isolation of Tissue‐Specific Extracellular Vesicles From the Blood
Newman, L. A., & Rowland, A. (2025) · Journal of Extracellular Biology · doi:10.1002/jex2.70059 · Cited by 28
Advances in Purification, Modification, and Application of Extracellular Vesicles for Novel Clinical Treatments
Matsuzaka, Y., & Yashiro, R. (2022) · Membranes · doi:10.3390/membranes12121244 · Cited by 28
The Potential Roles of Exosomes Carrying APP and Tau Cleavage Products in Alzheimer’s Disease
Zhao, Y., Gu, Y., Zhang, Q., Liu, H., & Liu, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051883 · Cited by 29
Exosomes for neurodegenerative diseases: diagnosis and targeted therapy
Tao, H., & Gao, B. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12329-w · Cited by 27
Extracellular vesicles in the study of Alzheimer's and Parkinson's diseases: Methodologies applied from cells to biofluids
Vaz, M., Martins, T. S., & Henriques, A. G. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15697 · Cited by 25
Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis
Mysiris, D. S., Vavougios, G. D., Karamichali, E., Papoutsopoulou, S., Stavrou, V. T., Papayianni, E., Boutlas, S., Mavridis, T., Foka, P., Zarogiannis, S. G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179739 · Cited by 25
Plasma versus serum for extracellular vesicle (EV) isolation: A duel for reproducibility and accuracy for CNS‐originating EVs biomarker analysis
Taha, H. B. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25231 · Cited by 25
Plasma BDNF Levels Following Transcranial Direct Current Stimulation Allow Prediction of Synaptic Plasticity and Memory Deficits in 3×Tg-AD Mice
Cocco, S., Rinaudo, M., Fusco, S., Longo, V., Gironi, K., Renna, P., Aceto, G., Mastrodonato, A., Puma, D. D. L., Podda, M. V., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00541 · Cited by 25
State-of-the-Art Methods and Emerging Fluid Biomarkers in the Diagnostics of Dementia—A Short Review and Diagnostic Algorithm
Solje, E., Benussi, A., Buratti, E., Remes, A. M., Haapasalo, A., & Borroni, B. (2021) · Diagnostics · doi:10.3390/diagnostics11050788 · Cited by 27
Neurotoxic and Neuroprotective Role of Exosomes in Parkinson’s Disease
Longoni, B., Fasciani, I., Kolachalam, S., Pietrantoni, I., Marampon, F., Petragnano, F., Aloisi, G., Coppolino, M. F., Rossi, M., Scarselli, M., et al. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191113103537 · Cited by 24
Novel Ultrasensitive Detection Technologies for the Identification of Early and Minimally Invasive Alzheimer’s Disease Blood Biomarkers
Álvarez‐Sánchez, L., Peña‐Bautista, C., Baquero, M., & Cháfer‐Pericás, C. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215093 · Cited by 25
Modulation of Amyloid-β and Tau in Alzheimer’s Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin® and Donepezil
Alvarez, X. A., Winston, C. N., Barlow, J. W., Sarsoza, F. M., Álvarez, I., Aleixandre, M., Linares, C., García-Fantini, M., Kastberger, B., Winter, S., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220575 · Cited by 23
Estimated glomerular filtration rate is a biomarker of cognitive impairment in Parkinson’s disease
Qu, Y., Qin, Q., Wang, D.-L., Li, J.-T., Zhao, J., An, K., Li, J., Mao, Z., Min, Z., Xiong, Y., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1130833 · Cited by 23
CX3CR1(+)/UCHL1(+) microglial extracellular vesicles in blood: a potential biomarker for multiple sclerosis
Duan, J., Lv, A., Guo, Z., Liu, Q., Tian, C., Yang, Y., Bi, J., Yu, X., Peng, G., Luo, B., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03243-z · Cited by 22
Self-citation
Approaches and Challenges in Characterizing the Molecular Content of Extracellular Vesicles for Biomarker Discovery
Kumari, S., Lausted, C. G., Scherler, K., Ng, A. H. C., Lü, Y., Lee, I., Hood, L., & Wang, K. (2024) · Biomolecules · doi:10.3390/biom14121599 · Cited by 25
Biomarkers and Tools for Predicting Alzheimer’s Disease in the Preclinical Stage
Li, T.-R., Yang, Q. Z., Hu, X., & Han, Y. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210524153901 · Cited by 23
The role of exosomes in the diagnosis of Parkinson's disease
Shi, Q., Kang, W., Liu, Z., & Zhu, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20595 · Cited by 22
Alpha-synuclein in peripheral body fluid as a biomarker for Parkinson’s disease
Shu, H., Zhang, P., & Gu, L. (2024) · Acta Neurologica Belgica · doi:10.1007/s13760-023-02452-2 · Cited by 25
Biomarker Organization in Circulating Extracellular Vesicles: New Applications in Detecting Neurodegenerative Diseases
Lim, C. Z. J., Natalia, A., Sundah, N. R., & Shao, H. (2020) · Advanced Biosystems · doi:10.1002/adbi.201900309 · Cited by 23
Neuronally-derived tau is increased in experienced breachers and is associated with neurobehavioral symptoms
Edwards, K. A., Greer, K., Leete, J. J., Lai, C., Devoto, C., Qu, B., Yarnell, A. M., Polejaeva, E., Dell, K. C., LoPresti, M. L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97913-0 · Cited by 22
Characteristics of Exosomes and the Vascular Landscape Regulate Exosome Sequestration by Peripheral Tissues and Brain
Banks, W. A., Sharma, P., Hansen, K. M., Ludwig, N., & Whiteside, T. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012513 · Cited by 21
Self-citation
Blood-based CNS regionally and neuronally enriched extracellular vesicles carrying pTau217 for Alzheimer’s disease diagnosis and differential diagnosis
Guo, Z., Tian, C., Shi, Y., Song, X., Yin, W., Tao, Q., Liu, J., Peng, G.-P., Wu, Z., Wang, Y., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01727-w · Cited by 23
Self-citation
Fluid‐based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseases
Brinkmalm, A., Portelius, E., Brinkmalm, G., Pannee, J., Dahlén, R., Gobom, J., Blennow, K., & Zetterberg, H. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14594 · Cited by 23
Secreted Extracellular Vesicle Molecular Cargo as a Novel Liquid Biopsy Diagnostics of Central Nervous System Diseases
Monteiro-Reis, S., Carvalho-Maia, C., Bart, G., Vainio, S. J., Pedro, J., Silva, E. R., Sales, G., Henrique, R., & Jerónimo, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063267 · Cited by 21
The Potential Roles of Extracellular Vesicles as Biomarkers for Parkinson’s Disease: A Systematic Review
Valencia, J., Ferreira, M. S., Merino-Torres, J. F., Marcilla, A., & Soriano, J. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911508 · Cited by 20
Tauopathy promotes spinal cord-dependent production of toxic amyloid-beta in transgenic monkeys
Tu, Z., Yan, S., Han, B., Li, C., Liang, W., Lin, Y., Ding, Y., Wei, H., Wang, L., Xu, H., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01601-6 · Cited by 20
Blood extracellular vesicles carrying brain-specific mRNAs are potential biomarkers for detecting gene expression changes in the female brain
Smirnova, L., Modafferi, S., Schlett, C., Osborne, L. M., Payne, J. L., & Sabunciyan, S. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02384-6 · Cited by 20
Neuroimmune Circuits in Allergic Diseases
Cai, H., Zhu, X., & Sokol, C. L. (2025) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082423-032154 · Cited by 19
Contribution of Extracellular Vesicles and Molecular Chaperones in Age-Related Neurodegenerative Disorders of the CNS
Noori, L., Filip, K., Nazmara, Z., Mahakizadeh, S., Hassanzadeh, G., Bavisotto, C. C., Bucchieri, F., Marino, A., Cappello, F., Wnuk, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24020927 · Cited by 18
Evaluation of α‐synuclein in CNS ‐originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta‐analysis
Taha, H. B., & Ati, S. S. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14341 · Cited by 17
Biomarkers and Tools for Predicting Alzheimer's Disease in the Preclinical Stage
Li, T., Yang, Q. Z., Hu, X., & Han, Y. (2022) · Kölner Universitäts PublikationsServer (Universität zu Köln) · Cited by 17
Evaluation of ferritin and TfR level in plasma neural-derived exosomes as potential markers of Parkinson’s disease
Chen, Z.-T., Pan, C.-Z., Ruan, X.-L., Lei, L.-P., Lin, S.-M., Wang, Y., & Zhao, Z. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1216905 · Cited by 17
A meta-analysis of neurogenic exosomes in the diagnosis of Alzheimer's disease
Zhang, X., Liu, H., Huang, Y., & Wang, R. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20604 · Cited by 17
A Spectrum of Topics for 2019: Advances in Neuroinflammation, Oxidative Stress, Obesity, Diabetes Mellitus, Cardiovascular Disease, Autism, Exosomes, and Central Nervous System Diseases.
Banks, W. (2020) · Current pharmaceutical design · doi:10.2174/138161282601200225102049 · Cited by 7
Self-citation
Tau-Reactive Endogenous Antibodies: Origin, Functionality, and Implications for the Pathophysiology of Alzheimer’s Disease
Hromádková, L., & Ovsepian, S. V. (2019) · Journal of Immunology Research · doi:10.1155/2019/7406810 · Cited by 17
Astrocyte-Derived Exosomes in an iPSC Model of Bipolar Disorder
Attili, D., Schill, D. J., DeLong, C. J., Lim, K. C., Jiang, G., Campbell, K. F., Walker, K. A., Laszczyk, A. M., McInnis, M. G., & O’Shea, K. S. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-45493-7_8 · Cited by 15
Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation
Rhea, E. M., Logsdon, A. F., Banks, W. A., & Erickson, M. A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111120 · Cited by 15
Self-citation
Targeting the Cysteine Redox Proteome in Parkinson’s Disease: The Role of Glutathione Precursors and Beyond
Martínez, M. (2023) · Antioxidants · doi:10.3390/antiox12071373 · Cited by 14
Extracellular vesicles and their diagnostic potential in amyotrophic lateral sclerosis
Roy, J. W., Saucier, D., O’Connell, C. M., & Morin, P. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.07.012 · Cited by 15
Exosome: The “Off-the-Shelf” Cellular Nanocomponent as a Potential Pathogenic Agent, a Disease Biomarker, and Neurotherapeutics
Ghosh, S., & Ghosh, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.878058 · Cited by 13
Extracellular vesicles: A new paradigm in understanding, diagnosing and treating neurodegenerative disease
Dar, G. H., Badierah, R., Nathan, E., Bhat, M. A., Dar, A. H., & Redwan, E. M. M. M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.967231 · Cited by 13
Potential of exosomes for targeted therapy in neuroinfectious disease management: crossing the blood–brain barrier
Bukke, S. P. N., Yadav, S., Prajapati, S., Rani, S. S., Reddy, M. S., Thalluri, C., Chettupalli, A. K., Goruntla, N., Pradeepkumar, B., Eftekhari, Z., et al. (2025) · Tissue Barriers · doi:10.1080/21688370.2025.2607157 · Cited by 12
Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer’s disease patients and cognitively normal individuals
Boyer, E., Deltenre, L., Dourte, M., Colmant, L., Paître, E., Sleegers, K., Suelves, N., Hanseeuw, B. J., & Kienlen‐Campard, P. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01508-6 · Cited by 16
Prospects for the Use of Small Extracellular Vesicles as a Transport Vehicle through the Blood–Brain Barrier
Хаспеков, Л. Г., & Yakovlev, A. A. (2023) · Neurochemical Journal · doi:10.1134/s1819712423010087 · Cited by 12
Extracellular Vesicle‐Derived microRNAs as Fluid Biomarkers in Neurodegenerative Diseases: A Systematic Review
Zaman, A., Drake, S., & Fournier, A. E. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70323 · Cited by 14
Intrinsic factors behind long‐COVID: II. SARS‐CoV‐2, extracellular vesicles, and neurological disorders
El‐Maradny, Y. A., Rubio‐Casillas, A., Mohamed, K. I., Uversky, V. N., & Redwan, E. M. M. M. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30486 · Cited by 10
Systematic analysis of multi-omics data reveals component-specific blood-based biomarkers for Parkinson’s disease
Tng, T. J. W., Wong, B. W. Y., Sim, E. H. Y., Tan, E., Goh, W. W. B., & Lim, K. (2024) · Translational Medicine Communications · doi:10.1186/s41231-024-00169-9 · Cited by 10
An Update on Peripheral Blood Extracellular Vesicles as Biomarkers for Parkinson's Disease Diagnosis
Wang, K., Shen, J., & Xu, Y. C. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.11.017 · Cited by 10
The Biology, Pathological Roles of Exosomes and Their Clinical Application in Parkinson’s Disease
Huang, J., Yuan, X., Chen, L., Hu, B., Wang, H., & Huang, W. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.09.001 · Cited by 9
The potential of exosomal biomarkers: Revolutionizing Parkinson's disease: How do they influence pathogenesis, diagnosis, and therapeutic strategies?
Akbari‐Gharalari, N., Ghahremani‐Nasab, M., Naderi, R., Chodari, L., & Nezhadshahmohammad, F. (2024) · AIMS neuroscience · doi:10.3934/neuroscience.2024023 · Cited by 10
The Fatal Role of Enterohaemorrhagic Escherichia coli Shiga Toxin-associated Extracellular Vesicles in Host Cells
Lee, K., Park, J.-Y., Jeong, Y., & Lee, M. (2023) · The Journal of Microbiology · doi:10.1007/s12275-023-00066-0 · Cited by 9
Neuronal-enriched small extracellular vesicles trigger a PD-L1-mediated broad suppression of T cells in Parkinson’s disease
Chen, Z., Li, W., Meng, B., Xu, C., Huang, Y., Li, G., Wen, Z., Liu, J., & Mao, Z. (2024) · iScience · doi:10.1016/j.isci.2024.110243 · Cited by 10
The Role of Extracellular Vesicles in Brain‐Peripheral Communication Following Ischemic Stroke: Implications for Neural Repair and Regeneration
de Rezende, V. L., Mathias, K., da Costa, M. D. A., Gonçalves, C. L., Barichello, T., & Petronilho, F. C. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70155 · Cited by 8
The Potency of Biomarkers for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease
Shahraki, M. S., Sourani, Z., Behdarvand, F., Mousavi, M. M., & Shirian, S. (2022) · The Neuroscience Journal of Shefaye Khatam · doi:10.61186/shefa.10.2.91 · Cited by 8
Proteomic Complexity in Parkinson’s Disease: A Redox Signaling Perspective of the Pathophysiology and Progression
Martínez, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.11.006 · Cited by 8
Zebrafish brain RNA sequencing reveals that cell adhesion molecules are critical in brain aging
Erbaba, B., Burhan, Ö. P., Şerifoğlu, N., Muratoğlu, B., Kahveci, F., Adams, M. M., & Arslan-Ergül, A. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.04.017 · Cited by 8
The Head and the Heart
Jensen, B. C., & Willis, M. S. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.934 · Cited by 8
The quest for Parkinson’s disease biomarkers: traditional and emerging multi-omics approaches
Sharma, P., & Dhamija, R. K. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10929-x · Cited by 7
How close are we to a breakthrough? The hunt for blood biomarkers in Parkinson's disease diagnosis
Liu, C., Su, Y., Ma, X., Wei, Y., & Qiao, R. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16290 · Cited by 6
Association between T‐tau protein and Aβ42 in plasma neuronal‐derived exosomes and cognitive impairment in patients with permanent atrial fibrillation and the role of anticoagulant therapy and inflammatory mechanisms
Du, M., Wang, X., Ma, F., Li, F., Li, H., Li, F., Zhang, A., & Gao, Y. (2022) · Journal of Cardiac Surgery · doi:10.1111/jocs.16248 · Cited by 6
Rethinking the reliability and accuracy of biomarkers in CNS-originating EVs for Parkinson's disease and multiple system atrophy
Taha, H. B. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1192115 · Cited by 5
Extracellular vesicles in Alzheimer's disease
Pinho, V. H. B., Daher, J. P. L., Kanaan, S., & Medeiros, T. (2024) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0044-1779296 · Cited by 6
Longitudinal decline in DAT binding in Parkinson’s disease: connections with sleep disturbances
Ren, J., Xie, H., Weng, Y., Ge, Y., Yao, R., Jiang, Z., Zhang, J., Zhu, Y., Fu, X., Wang, J., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03766-5 · Cited by 5
Self-citation
Role of neuroglia cell-derived microvesicles in cobalt chloride-induced mitochondrial autophagy in neurons
Li, H., Zheng, F., Shao, W., Yu, G., Hu, H., Guo, Z., Wu, S., Tang, Y., & Li, H. (2025) · Toxicology · doi:10.1016/j.tox.2025.154214 · Cited by 5
The promise and challenges of extracellular vesicles in the diagnosis of neurodegenerative diseases
Hagey, D. W., & Andaloussi, S. E. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00014-x · Cited by 5
Magnetic Particle-Based Immunoprecipitation of Nanoscale Extracellular Vesicles from Biofluids
Heinzelman, P. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7652-2_8 · Cited by 5
Whispers in the Brain: Extracellular Vesicles in Neuropathology and the Diagnostic Alchemy of Neurological Diseases
Işık, M., Sari, H. K., Çağlayan, M. G., Yılmaz, R., & Derkuş, B. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70090 · Cited by 4
Differential roles of human tau isoforms in the modulation of inflammation and development of neuropathology
Spencer, B. J., Schueler, A., Sung, D., & Rissman, R. A. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106942 · Cited by 4
Exosomal MYD88 isolated from 4T1 breast cancer cells using microfluidic chips promotes depressive-like behavior through neural remodeling in the mPFC
Zhou, B., Ma, H., Li, Y., He, T., Yao, X., Liu, B., Guo, J., Zhang, J., & Zhang, H. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106171 · Cited by 3
Self-citation
Biomarkers for Lewy body diseases and other alpha-synucleinopathies in biofluids: current evidence and future directions
Russotto, A., Longobardi, A., Ciullini, A., Cazzaniga, F. A., Bacınoğlu, M. B., Borroni, B., Ghidoni, R., Moda, F., & Saraceno, C. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07471-6 · Cited by 5
Exosomes as a Future Diagnostic Tool for Brain Disorders
Bhawale, R., Vasave, R., & Mehra, N. K. (2024) · Springer eBooks · doi:10.1007/978-981-99-8373-5_14 · Cited by 3
Research progress on humoral biomarkers of Alzheimer’s disease: A review
Zhang, H., Fu, X., Yang, M., Song, X., Li, M., & Wang, X. (2024) · Medicine · doi:10.1097/md.0000000000038978 · Cited by 4
A Systematic Study and Potential Limitations of Proton-ELISA Platform for α-Synuclein Antigen Detection
Yang, C., Chang, J.-Y., Chen, M., & Lai, C. (2021) · Chemosensors · doi:10.3390/chemosensors10010005 · Cited by 3
miRNAs as biofluid markers for diagnostics of Alzheimer’s disease: recent status and perspectives
Kosikova, N., Cente, M., Cigánková, V., Koson, P., & Filipčík, P. (2018) · General Physiology and Biophysics · doi:10.4149/gpb_2018019 · Cited by 3
Biomarkers for Alzheimer's Disease
Panwar, D., Sharma, P., Sharma, S., Malik, M., & Kaur, J. (2024) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/979-8-3693-6442-0.ch003 · Cited by 1
Apoptotic extracellular vesicles: emerging biomarkers for cancer and neurodegenerative disease diagnostics
Soleymaninejadian, E., & Dehkordi, M. S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1619456 · Cited by 1
Clinical Utility of Small Extracellular Vesicles as Liquid Biopsy for Oral Mucosal Disease Diagnostics: Emerging Perspectives
Adebayo, O. F., Temilola, D. O., Owotade, F. J., & Chetty, M. (2026) · Diagnostics · doi:10.3390/diagnostics16071044 · Cited by 1
Metabolic and renal factors associated with plasma phosphorylated tau analytes used to detect Alzheimer's disease pathology
Yang, K. L., Ma, Y., Ennis, G. E., Jonaitis, E., Reyes, R. E. R., Johnson, S. C., Ashton, N. J., Blennow, K., Zetterberg, H., & Bendlin, B. B. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70383 · Cited by 2
Emerging biomarkers for Parkinson's disease in biological fluids
Rožanković, P. B., & Šimić, G. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1835751 · Cited by 1
Biomarkers in Alzheimer s Disease
Barcia, E. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.16.002855 · Cited by 1
Neuron-derived exosomes trigger a PD-L1-mediated broad suppression of T cells in Parkinson’s diseasePreprint
Chen, Z., Xu, C., Li, G., Wen, Z., Liu, J., & Mao, Z. (2022) · Research Square · doi:10.21203/rs.3.rs-2109216/v1 · Cited by 1
Fluorescence tagged salivary small extracellular vesicles as a nanotool in early diagnosis of Parkinson’s diseasePreprint
Rastogi, S., Rani, K., Rai, S., Singh, R., Sharma, V., Bharti, P. S., Kapoor, V., Vishwakarma, P., Batra, M., Rawat, S., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1621589/v2 · Cited by 1
Navigating the Molecular Maze of Alzheimer’s Disease: Developing A Human Hippocampal Atlas to Bridge Discovery and Clinical PracticePreprint
Wang, P., Wang, L., Tao, Q., Guo, Z., Luo, T., Xu, Z. P., He, Y., Yu, J., Liu, Y., Wu, Z., et al. (2023) · medRxiv · doi:10.1101/2023.12.06.23299593 · Cited by 1
Self-citation
Metabolic factors associated with plasma phosphorylated tau analytes used to detect Alzheimer’s disease pathologyPreprint
Yang, K. L., Ma, Y., Ennis, G. E., Jonaitis, E. M., Reyes, R. E. R., Johnson, S. C., Ashton, N. J., Blennow, K., Zetterberg, H., & Bendlin, B. B. (2025) · medRxiv · doi:10.1101/2025.07.27.25332280 · Cited by 1
Exosomes in Neurodegenerative Disorders
Elmehrath, A. O., Sonbol, Y. T., & Farghal, M. Y. (2020) · Springer eBooks · doi:10.1007/978-981-15-6599-1_8
Corrigendum: Evaluation of ferritin and TfR level in plasma neural-derived exosomes as potential markers of Parkinson's disease
Chen, Z.-T., Pan, C.-Z., Ruan, X.-L., Lei, L.-P., Lin, S.-M., Wang, Y., & Zhao, Z. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1355200
Outlooks of Using Small Extracellular Vesicles as a Transport Vehicle through the Blood–Brain Barrier
Хаспеков, Л. Г., & Yakovlev, A. A. (2023) · Нейрохимия · doi:10.31857/s1027813323010089
Extracellular Vesicles as Biomarkers of Alzheimer Disease and Related Dementias
Mianoor, Z., Phelps, J., & Badhwar, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_18
Additional file 1 of β-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer’s disease and predicts cerebral amyloidosis
Li, T.-R., Yao, Y., Jiang, X.-Y., Dong, Q.-Y., Yu, X.-F., Wang, T., Cai, Y.-N., & Han, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19759551
Additional file 1 of Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson’s disease pathogenesis
Sheng, L., Stewart, T., Yang, D., Thorland, E., Soltys, D., Aro, P., Khrisat, T., Xie, Z., Li, N., Liu, Z., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12629109
Self-citation
Additional file 1 of Blood-based CNS regionally and neuronally enriched extracellular vesicles carrying pTau217 for Alzheimer’s disease diagnosis and differential diagnosis
Guo, Z., Tian, C., Shi, Y., Song, X.-R., Yin, W., Tao, Q.-Q., Liu, J., Peng, G.-P., Wu, Z.-Y., Wang, Y.-J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26689169
Self-citation
Additional file 1 of Fluorescence-tagged salivary small extracellular vesicles as a nanotool in early diagnosis of Parkinson’s disease
Rastogi, S., Rani, K., Rai, S., Singh, R., Bharti, P. S., Sharma, V., Sahu, J., Kapoor, V., Vishwakarma, P., Garg, S., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24089206
Additional file 2 of Blood-based CNS regionally and neuronally enriched extracellular vesicles carrying pTau217 for Alzheimer’s disease diagnosis and differential diagnosis
Guo, Z., Tian, C., Shi, Y., Song, X.-R., Yin, W., Tao, Q.-Q., Liu, J., Peng, G.-P., Wu, Z.-Y., Wang, Y.-J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26689172
Self-citation

Authors: Shi, M., Kovac, A., Korff, A., Cook, T. J., Ginghina, C., Bullock, K. M., Yang, L., Stewart, T., Zheng, D., Aro, P., Atik, A., Kerr, K. F., Zabetian, C. P., Peskind, E. R., Hu, S., Quinn, J. F., Galasko, D. R., Montine, T. J., Banks, W. A., & Zhang, J.
Affiliations: University of Washington (US)
Geriatric Research, Education, and Clinical Center Veterans Affairs Puget Sound Health Care System Seattle WA USA
Department of Pathology University of Washington School of Medicine Seattle WA USA
Oregon Health & Science University (US)
University of California San Diego (US)
Corresponding author: Zhang, Jing
ORCID: Shi, Min
Zheng, Danfeng
Kerr, Kathleen F.
Zabetian, Cyrus P.
Peskind, Elaine R.
Hu, Shu‐Ching
Quinn, Joseph F.
Galasko, Douglas R.
Montine, Thomas J.
Banks, William A.
Zhang, Jing
Venue: Alzheimer's & Dementia
Publisher: Wiley
Published: 2016-05-24
Volume: 12
Issue: 11
Pages: 1125-1131
ISSN: 1552-5260 (ISSN-L)
1552-5279
DOI: 10.1016/j.jalz.2016.04.003
PMC: PMC5107127
OpenAlex: W2398356848
Cited by: 206
References: 29
Citations by year: 2026: 8 · 2025: 15 · 2024: 29 · 2023: 27 · 2022: 29 · 2021: 24 · 2020: 31 · 2019: 16 · 2018: 17 · 2017: 6 · 2016: 4
FWCI: 11.54
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Alzheimer s & Dementia (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institutes of Health (U01 NS082137, P30 ES007033‐6364, R01 AG033398, R01 ES016873, R01 ES019277, R01 NS057567, P50 NS062684‐6221, R21 NS085425, R01 NS065070, P50 AG05131)
Alzheimer's Association (2015‐NIRG‐342009)
U.S. Department of Veterans Affairs
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: tau protein
MeSH terms: Adult, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Biological Transport, Blood-Brain Barrier, Female, Humans, Male, Mice, Inbred C57BL, Middle Aged, Parkinson Disease, tau Proteins, Mice, Knockout, Neural Cell Adhesion Molecule L1, Exosomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks